期刊文献+

丝素蛋白/羟基磷灰石组织工程化骨修复兔桡骨节段性骨缺损 被引量:1

Repairing radial segmental bone defects with tissue engineered bone of silk fibroin/hydroxyapatite in rabbits
原文传递
导出
摘要 目的 探讨丝素蛋白/羟基磷灰石(SF/HA)组织工程化骨的成骨作用,以期为临床治疗骨缺损提供新的人工骨材料.方法 将SF/HA与成骨诱导的兔骨髓基质干细胞(BMSCs)复合,构建组织工程化骨.取54只兔于左侧桡骨中上段制备15 mm节段性骨缺损.实验分3组(A、B组各24只,C组6只):A组:植入SF/HA组织工程化骨,B组:单纯植入SF/HA;C组:骨缺损区不植入任何材料.于术后4、8、12及16周摄X线片,并于16周行螺旋CT扫描重建,观察骨缺损修复及骨塑形情况,参照Lane-Sandhu X线评分标准对各组骨缺损的骨修复程度评分.骨痂标本行 HE染色组织学观察,按照Lane-Sandhu组织学评分法比较12周和16周时各组的骨修复情况. 结果 术后16周,X线片示A组髓腔通畅,新骨塑形好,骨皮质连续;B组缺损区有缩小,两断端不连接;C组缺损区无明显骨痂生长.16周时螺旋CT扫描重建显示:A组骨塑形明显,骨缺损完全修复;B组有部分皮质骨形成,缺损区不能完全修复;C组骨缺损基本无修复.每组术后4、8、12、16周不同时间点的放射学评分差异均有统计学意义(P<0.05).术后12、16周时3组间Lane-Sandhu组织学评分差异均有统计学意义(P<0.05). 结论 SF/HA组织工程化骨具有良好的节段性骨缺损修复能力,但SF/HA本身缺乏骨诱导作用,单独修复节段性骨缺损作用有限. Objective To explore the bone formation of silk fibroin/hydroxyapatite (SF/HA)co-cultured with bone marrow stromal cells (BMSCs) in rabbits. Methods The purified, culture-expanded and osteogenic BMSCs were combined with SF/HA in vitro to construct a tissue engineered bone. A segmental bone defect (15 mm in length) was created at each left radius in the rabbits which were randomized into 3 groups. The tissue engineered bone was implanted through open operation into the bone defects in Group 1. Group 2 was implanted with SF/HA scaffold alone, and Group 3 without any implant (unfilled). Bone formation and moulding were observed by X-ray at 4, 8, 12 and 16 weeks and by spiral CT reconstruction at 16 weeks. Results The rate and quality of new bone formation were significantly different among Group 1, Group 2 and Group 3 by radiography and histological scores ( P 〈 0. 05). The segmental bone defects were completely united in Group 1, but partially united in Group 2. There was no new bone formation and the defects were only repaired by fibrous tissue in Group 3. Conclusion SF/HA with BMSCs has a good ability of repairing segmental bone defects.
出处 《中华创伤骨科杂志》 CAS CSCD 2010年第8期766-770,共5页 Chinese Journal of Orthopaedic Trauma
基金 江苏省基础研究计划(自然科学基金)(BK2008008)
关键词 丝素蛋白 羟基磷灰石类 组织工程 骨缺损 Silk Hydroxyapatites Tissue engineering Bone defect Rabbits
  • 相关文献

参考文献21

  • 1Smartt JM Jr,Karmacharya J,Gannon FH,et al.Repair of the immature and mature craniofacial skeleton with a carbonated calcium phosphate cement:assessment of biocompatibility,osteoconductivity,and remodeling capacity.Plast Reconstr Surg,2005,115:1642-1650.
  • 2DeCoster TA,Gehlert RJ,Mikola EA,et al.Management of posttraumatic segmental bone defects.J Am Acad Orthop Surg,2004,12:28-38.
  • 3Fialkov JA,Holy CE,Shoichet MS,et al.In vivo bone enginering in a rabbit femur.J Cranioface Surg,2003,14:324-332.
  • 4Mankin HJ.The changes in major limb reconstruction as a result of the development of allografts.Chir Organi Mov,2003,88:101-113.
  • 5Khan SN,Cammisa FP Jr,Sandhu HS,et al.The biology of bone grafting.J Am Acad Orthop Surg,2005,13:77-86.
  • 6Zijderveld SA,ten Bruggenkate CM,van Den Bergh JP,et al.Fractures of the iliac crest after split-thickness bone grafting for preprosthetic surgery:report of 3 cases and review of the literature.J Oral Maxillofac Surg,2004,62:781-786.
  • 7Enneking WF,Campanacci DA.Retrieved human allografts:a clinicopathological study.J Bone Joint Surg (Am),2001,83:971-986.
  • 8Boone DW.Complications of iliac crest graft and bone grafting alternatives in foot and ankle surgery.Foot Ankle Clin,2003,8:1-14.
  • 9曹谊林,周广东.21世纪组织工程面临的机遇与挑战[J].中华医学杂志,2005,85(36):2523-2525. 被引量:7
  • 10Lane JM,Sandhu HS.Current approaches to experimental bone grafting.Orthop Clin North Am,1987,18:213-225.

二级参考文献46

  • 1马金忠.人工骨—羟基磷灰石[J].中华手外科杂志,1993,9(3):183-185. 被引量:2
  • 2Frayssinet P,Rouquet N,Mathon D Histological integration of allogeneic cancellous bone tissue treated by supercritical CO2 implanted in sheep bones.Biomaterials,1998,19:2247-2253.
  • 3Zellin G,Gritli-Linde A,Linde A.Healing of mandibular defects with different biodegradable and non-biodegradable membranes:an experimental study in rats.Biomaterials,1995,16:601-609.
  • 4Gerecht-Nir S, Itskovitz-Eldor J. Cell therapy using human embryonic stem cells. Transpl Immunol, 2004, 12:203-209.
  • 5Atala A, Koh CJ. Tissue engineering applications of therapeutic cloning. Annu Rev Biomed Eng, 2004, 6:27-40.
  • 6Vrana KE, Hipp JD, Goss AM, et al. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci USA, 2003, 100:11911-11916.
  • 7Majka M, Kucia M, Ratajczak MZ. Stem cell biology - a never ending quest for understanding. Acta Biochim Pol, 2005, 52:353-358.
  • 8Yarlagadda PK, Chandrasekharan M, Shyan JY. Recent advances and current developments in tissue scaffolding. Mater Eng, 2005,15 : 159-177.
  • 9Nair LS, Bhattacharyya S, Laurencin CT. Development of novel tissue engineering scaffolds via electrospinning. Expert Opin Biol Ther, 2004, 4:659-668.
  • 10Shieh SJ, Vacanti JP. State-of-the-art tissue engineering:from tissue engineering to organ building. Surgery, 2005, 137 : 1-7.

共引文献25

同被引文献16

  • 1侯锐,程晓兵,毛天球,陈富林,杨耀武,吴炜.多孔β-磷酸三钙陶瓷支架材料对骨髓基质细胞增殖及分化作用的实验研究[J].口腔医学研究,2006,22(3):236-238. 被引量:6
  • 2郑晓雁,张振庭,方玉.MTT法评价国产碳纤维桩材料的细胞毒性[J].北京口腔医学,2006,14(3):189-191. 被引量:22
  • 3Younger EM, Chapman MW. Morbidity at bone graft donn or site [J]. J Orthop Trauma 1989, 3( 3 ): 192-195.
  • 4Arrington ED, Smith WJ, Chambers HG, et al. Complications of Iilaccrest bone graft harvesting[J]. Clin Orthop Relat Res, 1996, 329 : 300-309.
  • 5Nobuaki Shirasu, Takaaki Ueno, Yasuhisa Hiram, et al. Bone for- mation in a rat calvarial defect model after transplanting autogen- ous bone marrow with beta-tricalcium phosphate[J]. Acta histo- chemica, 2010, 112 : 270-277.
  • 6Akamaru T, Sub D, Boden S, et al. Simple carrier matrix modific- ations can enhance delivery of recombinant human bone morpho- genetic protein-2 for posterolateral spine fusion[J]. Spine, 2003, 1 ( 28 ): 429-434.
  • 7Boden SD. Overview of the biology of lumbar spine fusion and principles for selceting a bone graft substitute[J]. Spine, 2002, 165 ( 27 ): 526-531.
  • 8Epstein, NE. An analysis ofnoninstrumented posterolateral lumbar fusion performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate [J]. The Spine Journal, 2008, 8 : 882-887.
  • 9Epstein, NE. Beta tricalcium phosphate: observation of use in 100 posterolateral lumbar instrumented fusions[J]. The Spine Journal, 2009, 9 : 630-638.
  • 10Itoh H, Ehara S, Kamimura M, et al. Experimental spinal fusion with use of recombinant human morphogenetic protein 2 [J]. Spine, 1999, 24( 14 ): 1402-1405.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部